BMO Capital Maintains Outperform on Centessa Pharmaceuticals, Maintains $15 Price Target
BMO Capital Maintains Outperform on Centessa Pharmaceuticals, Maintains $15 Price Target
BMO Capital維持Centessa Pharmicals的跑贏大盤,維持15美元的目標股價
BMO Capital analyst Kostas Biliouris maintains Centessa Pharmaceuticals (NASDAQ:CNTA) with a Outperform and maintains $15 price target.
BMO Capital分析師科斯塔斯·比利烏里斯維持Centessa Pharmicals(納斯達克股票代碼:CNTA)的跑贏大盤,目標股價維持15美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。